Reported Aug 16, 2017 · Terminated
Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company…
Cantrell Drug Company
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Cantrell Drug Company · 7321 Cantrell Rd · Little Rock, AR · 72207-4144
Is this the product you have?
- Glycopyrrolate Injection Solution, 2 mL 0.4 mg/2 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-16
- Lot codes and dates
- Lot #: 9781
- BUD
7/26/20179784
- BUD
7/27/20179822
- BUD
8/2/20179852
- BUD
8/5/201710061
- BUD
9/7/201710105
- BUD
9/13/201710150
- BUD
9/17/201710178
- BUD
9/22/201710185
- BUD
9/23/201710501
- BUD11/8/2017
- Amount recalled
- 21080 syringes
This recall covers 18 products
The agency filed one notice per product. You are reading one of them; the other 17 are below.
5 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Sterility Assurance.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Cantrell Drug Company recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.